Ajani JA - Search Results

1

Identification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted Metabolic Profiling.

Sanchez-Espiridion B, Liang D, Ajani JA, Liang S, Ye Y, Hildebrandt MA, Gu J, Wu X. Sanchez-Espiridion B, et al. Among authors: ajani ja. Clin Gastroenterol Hepatol. 2015 Oct;13(10):1730-1737.e9. doi: 10.1016/j.cgh.2015.05.023. Epub 2015 May 19. Clin Gastroenterol Hepatol. 2015. PMID: 25998788 Free PMC article.

2

Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years.

Yao JC, Tseng JF, Worah S, Hess KR, Mansfield PF, Crane CH, Schnirer II, Reddy S, Chiang SS, Najam A, Yu C, Giacco GG, Xie K, Wu TT, Feig BW, Pisters PW, Ajani JA. Yao JC, et al. Among authors: ajani ja. J Clin Oncol. 2005 May 1;23(13):3094-103. doi: 10.1200/JCO.2005.08.987. J Clin Oncol. 2005. PMID: 15860869

3

Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using comet assay.

Shao L, Lin J, Huang M, Ajani JA, Wu X. Shao L, et al. Among authors: ajani ja. Genes Chromosomes Cancer. 2005 Dec;44(4):415-22. doi: 10.1002/gcc.20254. Genes Chromosomes Cancer. 2005. PMID: 16114035

4

Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation.

Luthra R, Wu TT, Luthra MG, Izzo J, Lopez-Alvarez E, Zhang L, Bailey J, Lee JH, Bresalier R, Rashid A, Swisher SG, Ajani JA. Luthra R, et al. Among authors: ajani ja. J Clin Oncol. 2006 Jan 10;24(2):259-67. doi: 10.1200/JCO.2005.03.3688. Epub 2005 Dec 12. J Clin Oncol. 2006. PMID: 16344314

5

Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis.

Izzo JG, Malhotra U, Wu TT, Ensor J, Babenko IM, Swisher SG, Correa A, Bresalier RS, Hittelman WN, Ajani JA. Izzo JG, et al. Among authors: ajani ja. Semin Oncol. 2005 Dec;32(6 Suppl 9):S11-5. doi: 10.1053/j.seminoncol.2005.04.023. Semin Oncol. 2005. PMID: 16399423

6

Pharmacogenetics in esophageal cancer.

Wu X, Lu C, Chiang SS, Ajani JA. Wu X, et al. Among authors: ajani ja. Semin Oncol. 2005 Dec;32(6 Suppl 9):S87-9. doi: 10.1053/j.seminoncol.2005.04.031. Semin Oncol. 2005. PMID: 16399440

7

Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.

Wu X, Gu J, Wu TT, Swisher SG, Liao Z, Correa AM, Liu J, Etzel CJ, Amos CI, Huang M, Chiang SS, Milas L, Hittelman WN, Ajani JA. Wu X, et al. Among authors: ajani ja. J Clin Oncol. 2006 Aug 10;24(23):3789-98. doi: 10.1200/JCO.2005.03.6640. Epub 2006 Jun 19. J Clin Oncol. 2006. PMID: 16785472

8

Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.

Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Wang KL, et al. Among authors: ajani ja. Clin Cancer Res. 2006 Aug 1;12(15):4598-604. doi: 10.1158/1078-0432.CCR-06-0483. Clin Cancer Res. 2006. PMID: 16899607

9

Deficiency of cell cycle checkpoints and DNA repair system predispose individuals to esophageal cancer.

Shao L, Hittelman WN, Lin J, Yang H, Ajani JA, Wu X. Shao L, et al. Among authors: ajani ja. Mutat Res. 2006 Dec 1;602(1-2):143-50. doi: 10.1016/j.mrfmmm.2006.08.011. Epub 2006 Oct 2. Mutat Res. 2006. PMID: 17011594

10

Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancers.

Luthra MG, Ajani JA, Izzo J, Ensor J, Wu TT, Rashid A, Zhang L, Phan A, Fukami N, Luthra R. Luthra MG, et al. Among authors: ajani ja. Clin Cancer Res. 2007 Feb 1;13(3):912-9. doi: 10.1158/1078-0432.CCR-06-1577. Clin Cancer Res. 2007. PMID: 17289885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

779 results

Search Page